Hypoglycemia - PowerPoint Presen

Document Sample
Hypoglycemia - PowerPoint Presen Powered By Docstoc

Vandana Nayal, MD
Edited May 2005

 Plasma glucose less than 40 mg/dl
 Immediate questions
 1. Has a plasma blood sugar been sent to the
 2. Is the baby symptomatic?
 3. Is the mother a diabetic?
 4. How much glucose is the infant receiving?
     Measurement of glucose

 Bedside glucose strips can give incorrect values
  if the test is not done properly, if the strips used
  are too old, if the hematocrit is very high, or the
  glucose level is very low
 There is a wide variation when compared to
  laboratory determined plasma levels
   – Glucose concentration in whole blood is 10-15%
     lower than in plasma
 ALWAYS confirm your measurement in the lab
    Symptoms of hypoglycemia

 Apnea, hypotonia, irritability, irregular
  respirations, poor sucking or feeding,
  exaggerated Moro reflex, cyanosis, tremors, eye
  rolling, pallor, seizures, lethargy, temperature
  instability and coma
 Rarely bradycardia, tachycardia, high pitched cry,
  tachypnea, and vomiting
 Some have no symptoms despite documented
   Glucose requirement

How much glucose is the infant receiving
 in IV fluids?
Normal glucose requirement is 4-10
Check to be sure that calculations were
Causes of transient
 Perinatal stress
 Sepsis, esp. Gram-negative
 Asphyxia or HIE
 Hypothermia
 Polycythemia
 Shock
 Infant of diabetic mother
 Decreased glycogen stores
 Insufficient amount of glucose administered
 Maternal meds: terbutaline, propranolol
   Infants of diabetic mothers

40% of infants of diabetic mothers have
 documented hypoglycemia
Diabetic mothers have fluctuating
 hyperglycemia that results in fetal
  – induces pancreatic B-cell hyperplasia =
  – after delivery, hyperinsulism persists and
    hypoglycemia results
Decreased glycogen stores

 Intrauterine growth retardation or small
  for gestational age
 Premature infants
 Post-mature infants
Causes of persistent
Hormone excess - hyperinsulism
  –   Beckwith-Wiedemann syndrome
  –   Islet cell adenoma
  –   Beta cell hyperplasia, dysplasia
  –   Nesidioblastosis
Beckwith-Wiedemann syndrome
(because it is on the boards)
 Macroglossia,               Hepatomegaly,
  Omphalocele,                 hemihypertrophy,
  macrosomia, ear creases,     (increased malignancy)
  mild to mod mental           hepatoblastoma,
  deficiency                   immunodeficiency
 Large kidneys with renal    US and serial alpha feto
  medullary dysplasia,         protein every 6 months
  pancreatic hyperplasia       till the patient is 6 years
 Neonatal                     of age to r/o Wilms’s and
  polycythemia,cryptorchid     hepatoblastoma
  ism, hypoglycemia(1/2 to    Duplication of 11p15.5
  1/3 of cases) which is       causes BWS. IGF-2 gene
  responsive to HC             localization to 11p causes
Persistent hypoglycemia -
hormone deficiencies
 Growth hormone deficiency
 ACTH unresponsiveness
 Thyroid deficiency
 Epinephrine deficiency
 Glucagon deficiency
 Cortisol deficiency
 Hypoplastic pituitary
 Hypothalamic hormone deficiencies
 Midline CNS malformation
Defects in carbohydrate
Glycogen storage disease type 1
Fructose intolerance
Glycogen sythase deficiency
Fructose 1,6 diphosphatase deficiency
Defects in amino acid
Maple syrup urine disease
Propionic acidemia
Methylmalonic acidemia
3-Hydroxy-3-methylglutaryl-CoA lyase
Defects in fatty acid metabolism

Medium and long chain deficiency
Approach to hypoglycemia

History and physical
Evaluate infant for symptoms of
Look for signs of shock, sepsis, midline
 defects, or Beckwith-Wiedemann
Laboratory studies for transient
Serum glucose level should be sent to the
 lab to confirm the paper strip result
CBC with differential to evaluate for
 sepsis and to rule out polycythemia
    Persistent Hypoglycemia

 Initial studies – Serum glucose, insulin, cortisol,
  growth hormone at the time of hypoglycemic
  event; serum ketones
 Ratio of insulin to glucose is obtained
   – level of >0.3 indicates a non hyperinsulinemic cause
     of hypoglycemia
 Serum ketones are low or absent in the presence
  of hyperinsulinemia
Follow-up studies for persistent
 GH, Free Fatty acids, T3, T4, TSH
 Glucagon, uric acid, lactate, Alanine
 Ketone levels before and 15 min after
  administration of glucagon- 0.3mg/kg/dose
 Urine collection for AA, OA, catecholamines,
  specific reducing sugars
 Somatomedins (IGF-1, IGF-2, IGF binding
 Ultrasound or CT scan of the pancreas

Overall plan to maintain normoglycemia
 (level > 45 mg/dL)
Screen those at risk or those with
 symptoms suspicious for hypoglycemia
  – glucose check every 1-2 hr before feeds until
    glucose levels are stable, then every 4 hours
Determine why the baby is hypoglycemic
  – obvious reasons or need further work up?
At risk?

 Premature
 BW < 2500 g
 Smaller of discordant twins (wt. Diff. > 25%)
 Asphyxiated infant (5 min Apgar < 5)
 Infants of massively obese mothers
 Infants of diabetic mothers
 Infants with polycythemia, infection,
  microphallus/midline defects, anomalies
  associated with low glucose (BWS)
Asymptomatic hypoglycemia

 Treatment is controversial
 Term infants, first 6-12 hrs, not high risk
   – give early feeding
 Level < 25mg/dl is a medical emergency
   – give parenteral glucose - 2-3 ml/kg D10W IV over 2-3
 Check glucose q 15-30 minutes until stable
 Always follow your institution guidelines
Symptomatic, persistent, or
severe (< 25) hypoglycemia
 If chemstrip values persist < 40 mg/dL or initial
  < 25 mg/dl (confirmed by stat lab level)
   – Give bolus and start a glucose infusion of 6mg/kg/min
     even if the infant is asymptomatic
 Increase level of infusion until normoglycemia is
  achieved (> 45 mg/dL)
   – Peripheral IV can take up to D13 otherwise will need
     central access
 Check glucose levels q 15-30 minutes until stable
 Document improvement in symptoms

If an intravenous line cannot be started,
  glucagon can be given to infants with
  adequate glycogen stores
  – Infants of diabetic mothers have good stores
  – less effective in IUGR or SGA
Dose is 300mcg/kg not to exceed1mg total
  dose subcutaneously or IM while vascular
  access is attempted
Other treatments

 Trial of corticosteroids
   – Hydrocortisone sodium succinate mg/kg/day given
     intravenously or orally every 12 hours
   – prednisone 2mg/kg/day
 If hypoglycemia persists
   – Diazoxide (inhibits pancreatic insulin release)m8-
     15mg/kg/day PO in 2-3 divided doses or IV 3-
     5mg/kg/dose repeat in 20 min if no effect
 Somatostatin analog
   – Octreotide 2-10mcg/kg/day sc divided every 6-8h or
     continuous IV
 HGH 0.1unit/day

Shared By: